Adisseo expands Butyrate Portfolio with Sanion Tetra
Adisseo expands Butyrate Portfolio with Sanion Tetra Two new high concentration protected sodium butyrate solutions delivering proven performance and optimal handling
Read the full articleYou might also wanna read
AdBiotech Becomes No. 2 Shareholder of Pet Healthcare Firm Onhil
AdBiotech, an immunoglobulin specialist, acquired a 12.28% stake in pet healthcare firm Onhil for about 10 billion won, becoming its second-
Illumina to Supply SBS Chemistry for Broad Spinout's Spatial Perturb-Seq Platform
A supply agreement gives Bifrost Biosystems access to Illumina's chemistry for its optical pooled screening platform, slated for commercial
FATE Stock Jumps 6% As FDA Greenlights Moving Cell Therapy To Clinical Trials
The clearance allows the company to begin an early-stage basket trial in multiple autoimmune diseases later this year.
Carlyle faces regulatory divestiture demands in BASF deal; Incyte acquires Vega Therapeutics
Here’s what we’re watching in the chemical and pharmaceutical industries this week
cen.acs.org·29d agoCelltrion's High-Margin Follow-On Products Expand Share in Europe
Celltrion's high-margin follow-on biosimilars are expanding their share across Europe, with Omlyclo reaching 16% and Vegzelma and Yuflyma ho
Spero Therapeutics Aktie: 85-Prozent-Potenzial bis 4 Dollar
Spero Therapeutics hat eigentlich Grund zum Feiern. Mitte Juni gab die US-Gesundheitsbehörde FDA grünes Licht für das neue Medikament Utebzi
Comments
Sign in to join the conversation.
No comments yet. Be the first.